Dr. Shu Pan, MD

Dr. Pan practices at Bass Medical Group in Oakland, California.

Dr. Pan's NPI, 1225476989, was assigned on June 4, 2013. Dr. Pan graduated from Renaissance School of Medicine at Stony Brook University in 2013. Dr. Pan holds California license A160005.

Dr. Pan's primary practice is Bass Medical Group, at 3300 Webster St, Oakland, CA 94609 in Alameda County. The practice phone is (925) 932-6330.

Dr. Pan's primary practice is Bass Medical Group in Oakland, California. Dr. Pan is also affiliated with Alta Bates Summit Medical Center. The medical group on file is BASS Medical Group. Dmand AI also links Dr. Pan to 3 more hospitals, 2 group practices and clinics, 2 medical groups and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pan practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Pan's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Pan is board certified in urology by the American Board of Urology. Dmand AI has Dr. Pan's licenses on file in 2 states: California and Connecticut.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney stone disease, pelvic prolapse, prostate cancer and testicular dysfunction among the conditions Dr. Pan treats.

CMS data shows 3,654 Medicare services from Dr. Pan across 21 procedure codes in 2024, for 392 Medicare patients. Medicare paid $229,169 for them.

CMS counts 392 Medicare patients who saw Dr. Pan in 2024. The largest group is 65 to 74, with 159 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pan's median patient age at 71, with 18% women.

In 2024, Dr. Pan wrote 1,521 Medicare Part D claims for 361 patients. 79% of them were for generic drugs. CMS names the drug for 1,398 of them, across 14 drugs with 11 or more claims each, at $334,526 in total drug cost. In 2023, CMS named 1,402 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Pan for performance year 2024, reported individually. Dr. Pan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pan as offering telehealth. CMS counts 14 procedures of prostate resection by Dr. Pan, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 18 papers to Dr. Pan, published from 2015 to 2020. 2020 was the busiest year, with 5. The most frequent topics are Penile Prosthesis, Penile Implantation and Erectile Dysfunction. Dr. Pan has published most often in Int J Impot Res. Dr. Pan's most frequent co-authors are Ricardo M. Munarriz, MD, Martin Simon Gross, MD and Michel Apoj.

CMS Open Payments shows 485 general payments to Dr. Pan from 56 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 61% of the total. Ethicon Inc. paid the most, $3,086.

Dr. Pan graduated from Renaissance School of Medicine at Stony Brook University in 2013.

Dr. Pan is in network with 7 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.